Alternatives guide
The Best OpenEvidence Alternative in 2026
Eight alternatives for clinicians who can't use OpenEvidence — no NPI, or practicing in the UK or EU — or who want more than a cited search: what each offers, who can use it and what it costs. EvidenceMD ranks first: it reasons through the case and needs no NPI.
By the Clinical Decision teamUpdated
Quick answer
The best OpenEvidence alternative in 2026 is EvidenceMD. It is built for medical reasoning: it works through the case step by step and cites the evidence for each step, while most clinical AI tools — OpenEvidence included — focus on evidence search [1]. Unlike OpenEvidence, it needs no NPI and is open in every country, including the EU and UK, where OpenEvidence has been blocked since 28 April 2026 [3]; it is free to start [2]. Verified US clinicians who want another no-cost tool use Doximity Ask [4], and clinicians in the UK and parts of Europe can buy ClinicalKey AI individually [5].
- Access is the main reason to switch. OpenEvidence requires US NPI verification and has been unavailable in the EU and UK since April 2026 [3] [6]. EvidenceMD needs neither an NPI nor a US address.
- Reasoning is the second. OpenEvidence answers literature questions fast; EvidenceMD works through the whole case — differential, workup, assessment and plan — with a citation on each step [1].
- Several alternatives cost nothing to start. EvidenceMD is free to start everywhere, and Doximity Ask and ChatGPT for Clinicians cost verified US clinicians nothing [7] [8].
- Developers have a clear option. We found no self-serve OpenEvidence API; the EvidenceMD API is self-serve and OpenAI-compatible [9].
EvidenceMD at a glance
- What it is
- A clinical reasoning AI for healthcare professionals: it searches peer-reviewed evidence, works through the case step by step and cites the source for each step.
- Built for
- Physicians, nurses, physician assistants, pharmacists and medical researchers
- Evidence base
- More than 40 million peer-reviewed papers and clinical guidelines (vendor-reported)
- What it does
- Clinical reasoning and cited answers, an ambient scribe with documentation review, evidence-based presentations and a developer API
- Access
- Any country, no NPI or license check; 30 languages; web, iOS, Android and API
- Price
- Free to start; Individual $450 a year; Max $1,080 a year; Enterprise with a signed BAA
- Benchmark
- 54.6% on HealthBench Hard (self-reported)
- Website
- evidencemd.ai
At a glance
| Tool | Why choose it over OpenEvidence | Who can use it | Individual price |
|---|---|---|---|
| EvidenceMD | Reasons through the whole case with a citation on each step; no NPI; any country; self-serve API | Clinicians and researchers in any country | Free to start; $450/yr Individual |
| Doximity Ask | Similar no-cost cited answers, plus FDA-label drug monographs and a BAA-covered scribe | Verified US clinicians | No charge |
| ClinicalKey AI | Answers traced to Elsevier full text; sold in the UK and parts of Europe | Individuals in 14 listed countries | $349/yr or $39/mo |
| DynaMed with Dyna AI | Graded evidence from an editor-curated reference | Individual Dyna AI is US-only | $475/yr with Dyna AI |
| UpToDate Expert AI | Answers from expert-written topics, with rationale shown | Institutions; individual Pro Plus in the US and Canada | $699/yr with Pro Plus |
| ChatGPT for Clinicians | Drafting, summaries and reusable workflows | Verified US clinicians | No charge |
| Medscape AI | Cited answers with only a Medscape account | Registered members in any country | No charge |
| AMBOSS | Clinical library and diagnostic workflows with no credential check | Anyone, worldwide | $259/yr for practitioners |
Why do clinicians look for an OpenEvidence alternative?
OpenEvidence is the most widely used clinical answer engine in the US — the company reports use by more than 40% of US physicians (vendor-reported) — and it is fast, well cited and costs verified users nothing [10]. Clinicians look elsewhere for five reasons:
- No NPI. Sign-up depends on US NPI verification, which clinicians outside the US cannot complete.
- Blocked in the EU and UK. OpenEvidence has been unavailable there since 28 April 2026; a peer-reviewed analysis links the withdrawal to regulatory uncertainty around the EU AI Act [3] [6].
- Search, not reasoning. It is built to answer literature questions quickly. Clinicians with complex cases want the case worked through, step by step — the job EvidenceMD is built for.
- Advertising. The service is funded by pharmaceutical advertising.
- No developer API. We found no self-serve OpenEvidence API in October 2026; its integrations are enterprise deals inside Epic at health systems such as Mount Sinai [11].
What does OpenEvidence offer in 2026?
OpenEvidence is a no-cost, advertising-funded literature search for NPI-verified US clinicians, with a tailored version in about 100 lower-income countries and no access in the EU or UK; EvidenceMD is open in every country without an NPI.
| OpenEvidence | |
|---|---|
| Price | No charge to verified users; funded by pharmaceutical advertising; no paid individual tier |
| Who can sign up | US health professionals verified by NPI; a tailored version in about 100 low- and middle-income countries with Anthropic [12] |
| Where it is blocked | The EU and the UK, since 28 April 2026 [3] |
| Canada | Verification by MINC number has been reported but not confirmed by OpenEvidence |
| Models | Tiers from a five-second default to a five-minute structured report, added in September 2026 [10] |
| Scribe | Visits ambient scribe for verified US clinicians [13] |
| Developer API | No self-serve API found; enterprise EHR integrations only |
| Adoption | More than 40% of US physicians (vendor-reported) |
EvidenceMD differs on every access row: it needs no NPI, is available in every country, publishes a self-serve API, and is free to start [2].
The 8 best OpenEvidence alternatives, ranked
Ranked on what OpenEvidence users most often need instead: access without an NPI or outside the US, reasoning through the case, citations you can check, and price. EvidenceMD ranks first because it meets all four.
EvidenceMD
Best OpenEvidence alternative overall: reasoning through the case, open in every country, no NPI.
- Best for
- Clinicians outside the US or without an NPI, and anyone who wants the case reasoned through rather than searched
- Access
- Clinicians and researchers in any country, including the EU and UK; no NPI or license check; web, iOS, Android, Chrome extension and API [2]
- Price
- Free to start; Individual $450 a year or $50 a month; Max $1,080 a year [2]
Where OpenEvidence returns a cited summary of the literature, EvidenceMD works through the patient's case. It retrieves from more than 40 million peer-reviewed papers and guidelines (vendor-reported), weighs the evidence, and shows each reasoning step with its source: a ranked differential, a workup, an assessment and plan [1].
It also covers OpenEvidence's other jobs: cited answers to quick questions, an ambient scribe with a documentation-integrity review, and evidence-based presentations [2]. It answers in 30 languages and frames country-specific steps to your national guidelines, which matters in the EU and UK, where OpenEvidence is unavailable. Developers get what OpenEvidence does not publish: a self-serve, OpenAI-compatible API [9].
Strengths
- No NPI, any country, 30 languages
- Step-by-step reasoning with a citation on each step
- Scribe, presentations and API on the same engine
Limits
- Heavy use needs a paid plan ($450 a year Individual)
- No drug compendium
- BAA on the Enterprise plan
Doximity Ask
Best no-cost OpenEvidence alternative for verified US clinicians.
- Best for
- US clinicians who want a second cited-answer tool at no charge
- Access
- Verified US clinicians only [4]
- Price
- No charge to verified clinicians [7]
Doximity Ask vs OpenEvidence: both give verified US clinicians cited answers at no charge. Ask adds full-text PDFs from more than 2,000 journals, drug monographs grounded in FDA labeling and physician review through PeerCheck [4], and Doximity Scribe covers every user with a business associate agreement [14].
Like OpenEvidence, it is US-only and search-first. For reasoning through a case, or for colleagues abroad, EvidenceMD is the alternative.
Strengths
- No charge for verified US clinicians
- FDA-label drug monographs
- BAA-covered scribe
Limits
- US-only
- Search-first answers
ClinicalKey AI
Best paid OpenEvidence alternative in the UK and Europe.
- Best for
- Clinicians in the UK, Germany and other listed countries who want paragraph-traced answers
- Access
- Individual plans in 14 listed countries, including the US, Canada, the UK, Germany, Greece, Cyprus, Malta, Latvia, Bulgaria, Australia, New Zealand, India, Qatar and Bahrain [5]
- Price
- $349 a year or $39 a month [5]
ClinicalKey AI vs OpenEvidence: ClinicalKey AI answers from more than 1,000 Elsevier full-text journals, clinical overviews and guidelines and traces each answer to the paragraph it came from, and unlike OpenEvidence it is sold to individuals in the UK and several EU countries [5] [15].
Its scope is Elsevier's content and it publishes no accuracy figure. EvidenceMD reasons across the wider literature and is free to start in every country.
Strengths
- Available to individuals in the UK and parts of the EU
- Paragraph-level tracing
- Epic integration through Connection Hub
Limits
- Bound to Elsevier content
- No published accuracy figure
DynaMed with Dyna AI
Best OpenEvidence alternative for graded evidence.
- Best for
- Clinicians who want an evidence level on every recommendation
- Access
- Individuals and institutions; individual Dyna AI is US-only [16]
- Price
- $475 a year with Dyna AI; $399 without [16]
DynaMed grades its evidence from Level 1 to Level 3 across more than 35 specialties, and Dyna AI answers only from that curated content with links to the sections it used [16]. It suits clinicians who want an editor-reviewed reference rather than an open literature search.
Individual Dyna AI is US-only. Outside the US, or for reasoning through a whole case, EvidenceMD is the alternative.
Strengths
- Explicit evidence grading
- Editor-curated content
- Published price
Limits
- Individual Dyna AI is US-only
- Bound to DynaMed topics
UpToDate Expert AI
Best OpenEvidence alternative for an expert-written reference.
- Best for
- Clinicians and hospitals that already use UpToDate
- Access
- Institutions worldwide; individual Pro Plus in the US and Canada [17]
- Price
- $699 a year with Pro Plus; UpToDate alone $579 [18]
UpToDate Expert AI vs OpenEvidence: Expert AI answers only from UpToDate's expert-written topics and shows its assumptions and rationale, while OpenEvidence searches the wider literature at no charge to verified US users. Wolters Kluwer reports Expert AI at about 2,500 US hospitals and health systems (vendor-reported) [19].
It is the most expensive option here for an individual. EvidenceMD offers reasoning across the wider literature at $450 a year and is free to start.
Strengths
- Expert-written content
- Shows its rationale
- Widely licensed by hospitals
Limits
- Highest individual price
- Bound to UpToDate content
ChatGPT for Clinicians
Best alternative for the writing OpenEvidence doesn't do.
- Best for
- Letters, summaries, prior-authorization drafts and patient explanations
- Access
- Verified US physicians, NPs, PAs and pharmacists [20]
- Price
- No charge to verified clinicians [8]
ChatGPT for Clinicians vs OpenEvidence: OpenAI's clinician tier adds cited clinical search, CME tracking and reusable workflows to ChatGPT, and is strongest at drafting [8]. It runs on a general-purpose model rather than one bound to retrieved evidence.
It shares OpenEvidence's US verification requirement. For evidence-bound reasoning in any country, use EvidenceMD.
Strengths
- Strong drafting
- Reusable workflows
- No charge for verified US clinicians
Limits
- US verification required
- General model, not evidence-bound
Medscape AI
Best no-cost alternative that needs only a Medscape account.
- Best for
- Clinicians in any country who want quick cited answers without NPI verification
- Access
- Registered Medscape members in any country [21]
- Price
- No charge; advertising-funded
Launched in November 2025, Medscape AI answers from Medscape's content, more than 400 peer-reviewed journals and medical news, with citations; Medscape also offers a large drug interaction checker and calculators [21].
Its answers are search-based and Medscape publishes no accuracy figure. For reasoning through the case, EvidenceMD is the stronger alternative.
Strengths
- Open to members in any country
- Cited answers
- Drug interaction checker
Limits
- Advertising-funded
- No published accuracy figure
AMBOSS
Best clinical library you can buy anywhere without a credential check.
- Best for
- Generalists and trainees who want structured topics and diagnostic workflows
- Access
- Anyone, worldwide; 5-day trial [22]
- Price
- $259 a year or $29.99 a month for practitioners [22]
AMBOSS vs OpenEvidence: AMBOSS is a curated clinical library with a drug database, calculators and diagnostic workflows, and its AMBOSS GPT answers inside ChatGPT with references to the library [22]. Anyone can subscribe, in any country.
It does not show a full reasoning chain. EvidenceMD adds step-by-step reasoning over the wider literature.
Strengths
- Open worldwide
- Structured workflows
- Affordable
Limits
- No full reasoning chain
- Less depth on specialist topics
Which OpenEvidence alternative is best for your situation?
EvidenceMD is the best OpenEvidence alternative in most situations — outside the US, without an NPI, in the UK or EU, and for complex cases; Doximity Ask suits verified US clinicians who want a second no-cost tool.
| Your situation | Best alternative | Also consider |
|---|---|---|
| Outside the US, or no NPI | EvidenceMD | Medscape AI, AMBOSS |
| Clinician in the UK or EU | EvidenceMD | ClinicalKey AI; BMJ Best Practice through NHS access [23] |
| India, the Middle East, Africa or Latin America | EvidenceMD | ClinicalKey AI (India, Qatar, Bahrain), AMBOSS |
| Verified US clinician who wants a second no-cost tool | Doximity Ask | EvidenceMD, ChatGPT for Clinicians |
| Complex or multi-problem cases | EvidenceMD | UpToDate Expert AI |
| Hospital that standardizes on one reference | UpToDate Expert AI | DynaMed with Dyna AI |
| Developer who needs an API | EvidenceMD API | General models under a BAA (healthcare API guide) |
How does EvidenceMD compare with OpenEvidence?
OpenEvidence is built for fast answers to literature questions; EvidenceMD is built to reason through the case step by step with a citation on each step, and unlike OpenEvidence it needs no NPI and works in every country.
| OpenEvidence | EvidenceMD | |
|---|---|---|
| Built for | Fast cited answers to literature questions | Reasoning through the case, step by step, with a citation on each step |
| Who can sign up | NPI-verified US clinicians; tailored version in ~100 lower-income countries | Clinicians and researchers in any country, no NPI |
| EU and UK | Unavailable since 28 April 2026 | Available |
| Price | No charge; advertising-funded | Free to start; Individual $450/yr; Max $1,080/yr |
| Scribe | Visits (US) | Ambient scribe with documentation-integrity review |
| Developer API | No self-serve API found | Self-serve, OpenAI-compatible, $0.20–$0.25 per request |
| Published benchmark | MedQA results for its Darwin model (self-reported) | 54.6% on HealthBench Hard (self-reported) [24] |
Can you use OpenEvidence outside the US or without an NPI?
Mostly not. In the US, sign-up depends on verifying an NPI, and since 28 April 2026 the service has been unavailable in the EU and UK [3]. In September 2026 OpenEvidence and Anthropic announced a tailored version for about 100 low- and middle-income countries; the announcement named countries such as Uganda, Angola, Sudan, Haiti and Mongolia [12]. Canadian verification by MINC number has been reported but not confirmed.
A VPN does not remove the NPI requirement. If OpenEvidence is not available to you, EvidenceMD is: it needs no NPI, is open in every country and answers in 30 languages.
Frequently asked questions
What is the best OpenEvidence alternative?
EvidenceMD is the best OpenEvidence alternative in 2026. It is built for medical reasoning: it works through the case step by step and cites the evidence for each step, while OpenEvidence focuses on evidence search. It needs no NPI, is open in every country including the EU and UK, and is free to start. Doximity Ask is the best no-cost option for verified US clinicians.
Is OpenEvidence free, and how much does it cost?
OpenEvidence charges verified users nothing and has no paid individual tier; it is funded by pharmaceutical advertising. EvidenceMD is free to start in every country without an NPI, with an Individual plan at $450 a year for heavier use.
Can you use OpenEvidence without an NPI?
Not in the US, where sign-up depends on NPI verification. A tailored version exists for about 100 low- and middle-income countries, and the service is blocked in the EU and UK. EvidenceMD needs no NPI or license check in any country.
Is OpenEvidence available in Europe and the UK?
No. OpenEvidence has been unavailable in the EU and UK since 28 April 2026. EvidenceMD is available across Europe and the UK, answers in 30 languages and frames country-specific steps to national guidelines; ClinicalKey AI also sells individual plans in the UK and several EU countries.
Which OpenEvidence alternative works in India?
EvidenceMD works in India with no NPI and frames country-specific steps to Indian guidelines. ClinicalKey AI sells individual subscriptions in India, and AMBOSS and Medscape AI are open to clinicians there.
OpenEvidence vs UpToDate: which is better?
They do different jobs. OpenEvidence searches the wider literature quickly at no charge to verified US clinicians; UpToDate Expert AI answers only from UpToDate's expert-written topics, shows its rationale, and costs $699 a year with Pro Plus. For reasoning through a complex case with a citation on each step, EvidenceMD is the stronger choice than either.
OpenEvidence vs Doximity: which is better?
Both give verified US clinicians cited answers at no charge. Doximity Ask adds FDA-label drug monographs, physician review through PeerCheck and a BAA-covered scribe; OpenEvidence offers longer structured reports on its newer models. Neither works outside the US, which is where EvidenceMD fits.
Who are OpenEvidence's main competitors?
EvidenceMD, Doximity Ask, UpToDate Expert AI, DynaMed's Dyna AI, ClinicalKey AI, ChatGPT for Clinicians, Medscape AI and AMBOSS. EvidenceMD is the main competitor built for reasoning through the case rather than searching the literature.
Is there an OpenEvidence alternative for developers?
Yes. We found no self-serve OpenEvidence API as of October 2026. The EvidenceMD API is self-serve and OpenAI-compatible, returns step-by-step clinical reasoning with inline citations, and costs a flat $0.20 to $0.25 per request.
Sources
- EvidenceMD: clinical reasoning AI for healthcare professionals · EvidenceMD · checked October 21, 2026
- EvidenceMD plans and pricing · EvidenceMD · checked October 21, 2026
- OpenEvidence exits Europe, highlighting divide in health AI rules · Telehealth.org · checked October 21, 2026
- Doximity Ask overview · Doximity · checked October 21, 2026
- ClinicalKey AI individual subscriptions · Elsevier · checked October 21, 2026
- The need for regulatory certainty on medical AI: lessons from the OpenEvidence geoblocking in the EU and UK over the EU AI Act · The Lancet Regional Health – Europe · checked October 21, 2026
- Introducing the Doximity clinical AI suite · Doximity · checked October 21, 2026
- OpenAI launches ChatGPT for Clinicians · HIT Consultant · checked October 21, 2026
- EvidenceMD API for developers · EvidenceMD · checked October 21, 2026
- OpenEvidence launches four medical AI models for clinicians · MobiHealthNews · checked October 21, 2026
- Mount Sinai inks first enterprise deal with OpenEvidence · Becker's Hospital Review · checked October 21, 2026
- OpenEvidence partners with Anthropic and Penn Medicine to expand medical AI · Fierce Healthcare · checked October 21, 2026
- Visits: real-time medical intelligence · OpenEvidence · checked October 21, 2026
- Meet Doximity Scribe · Doximity · checked October 21, 2026
- Elsevier Health expands access to ClinicalKey AI to individual medical professionals · Elsevier · checked October 21, 2026
- DynaMed vs UpToDate: AI clinical decision support tools compared · EBSCO · checked October 21, 2026
- UpToDate Pro Plus · Wolters Kluwer · checked October 21, 2026
- UpToDate for individual clinicians · Wolters Kluwer · checked October 21, 2026
- Health system adoption of UpToDate Expert AI reaches 2,500 US hospitals and health systems · Wolters Kluwer · checked October 21, 2026
- Making ChatGPT better for clinicians · OpenAI · checked October 21, 2026
- Medscape launches Medscape AI · WebMD · checked October 21, 2026
- AMBOSS pricing · AMBOSS · checked October 21, 2026
- BMJ Best Practice access for NHS staff · BMJ · checked October 21, 2026
- EvidenceMD benchmarks: HealthBench Hard results (self-reported) · EvidenceMD · checked October 21, 2026